TROYANOSYVIRUS
Zuruck zu CVEs

CVE-2022-30277

MEDIUM
5.7

Beschreibung

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

CVE Details

CVSS v3.1 Bewertung5.7
SchweregradMEDIUM
CVSS VektorCVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
AngriffsvektorPHYSICAL
KomplexitatLOW
Erforderliche PrivilegienLOW
BenutzerinteraktionREQUIRED
Veroffentlicht6/2/2022
Zuletzt geandert11/21/2024
Quellenvd
Honeypot-Sichtungen0

Betroffene Produkte

bd:synapsys

Schwachen (CWE)

CWE-613CWE-613

IOC Korrelationen

Keine Korrelationen erfasst

This product uses data from the NVD API but is not endorsed or certified by the NVD.